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The transplantation of animal organs into humans – xenotransplantation – has 
been under discussion for several years as a future supplement or even alterna-
tive to human organ donation. Besides the understandable (although not un-
contested) hopes, there have been plausible warnings of real and possibly dif-
ficult-to-control risks of infection to patients, their environment and ultimately 
the entire population. This contradictory and tense situation and the still largely 
unresolved potential of xenotransplantation require a sober review of the posi-
tion and unbiased assessment at all levels of society.
The present report on a commission by the Committee for Education, Research 
and Technology Assessment provides an overview of the international discus-
sion and, above all, of the (research and health) policy debate on the prospects 
for and challenges of xenotransplantation, essays a review of the current state 
of scientific and medical research, outlines the legal situation in Germany and 
central ethical issues and uses this as a basis to draw up suggestions for further 
scientific, political and social debate and need for action. The report deals with 
xenotransplantation of discrete organs, but not of tissues or cells.
THE INTERNATIONAL DEBATE
The growing interest in the potential and problems of this new medical tech-
nology is reflected in a growing number of expert reports, opinions and oth-
er documents on xenotransplantation commissioned by governments, national 
agencies or international organisations. Section II summarises the results of a 
comparative analysis of selected publications. Overall, the analysis shows grow-
ing scepticism regarding the hope that xenotransplantation can be developed in 
the foreseeable future into a low-risk therapeutic approach. Another striking 
feature is the almost unanimous call for guidelines for binding regulations to 
govern the launch of clinical trials and limit their potential risks.
MEDICAL AND SCIENTIFIC ASPECTS
The state of RD on xenotransplantation (section III) can be described in terms 
of three key issues: overcoming rejection, ensuring physiological functionality 
and mastering the risks of infection. Even in human organ transplants, rejection 
of foreign organs by the recipient immune system is still the biggest problem, 
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and implanting an animal organ into a human additionally involves defensive 
reactions which are not only more severe but also entirely different in nature 
(section III.1). Of these, only the so-called hyperacute rejection seems to be con-
trollable to some extent, primarily through advances in producing genetical-
ly modified pigs (pig organs). There is still immense need for research on the 
three other phases of rejection (acute vascular/delayed, cellular and chronic). 
The same is true of the question of physiological tolerance and functionality of 
the organs (section III.2), which has hardly been studied at all or has been im-
possible to study. Meanwhile, however, the most important issue in the debate 
is the substantial risk of infection (section III.3) by so far unknown probabloy 
viral pathogens, which would not only affect the recipient but also be a potential 
threat reaching far beyond their immediate surroundings. Here again, research is 
still in its infancy. Nevertheless, it is likely that clinical trials will start in only a 
few years. The time horizon for further dissemination of xenotransplantation is 
likely to be at least 15–20 years (section III.4).
A comparison with alternative technologies (artificial or bioartificial organs, 
therapy for the relevant diseases) also shows that these also are long-term op-
tions whose advantages and disadvantages should be thoroughly examined.
The review of the international state of research (section III.5) shows that Ger-
many is one of the leading locations for research in the field of xenotransplanta-
tion, alongside the dominant USA and UK.
LAW AND ETHICS
The unresolved risks of infection in particular have led to the almost unanimous 
view – even internationally speaking – that xenotransplantation needs special 
regulation, at least nationally, but basically internationally. Several countries 
have launched initiatives in this area or have already even created institutions. 
An overview of the legal situation in Germany (section IV) shows that while e. g. 
the legislation on drugs, genetic engineering and animal protection is relevant 
to xenotransplantation in the area covered (although not the Transplantation 
Act), there is reason to doubt that existing standards adequately deal with the 
significance of this medical neotechnology with consequences which are poten-
tial global in their dimensions. The identifiable need for research and action here 




The ethical debate (section V) shows two main emphases: consideration of mor-
al rights and interests of humans and exploration of the possible conflict be-
tween human and animal rights and interests. The human ethical aspects of 
xenotransplantation (section V.1) are particularly diverse, and mostly very close-
ly interrelated. Issues intensively discussed include e. g. reducing the shortage of 
transplantable organs, improving the equity in distribution, the ethics of human 
experiments, the current lack of any sign of an ability to deal with the infec-
tion risk, informed agreement and medical and social alternatives. The ethics of 
species and nature, and particularly the ethics of animals show clearly that the 
rights and interests of animals as »moral beings« are considerably endangered 
(section V.2). An ethical justification of xenotransplantation can accordingly 
only be achieved through carefully based and viable arguments. Ultimately, these 
are needed to answer the question whether human suffering has sufficient prior-
ity to justify acceptance of the sufferings and death of animals. Summarising the 
ethical debate, we can say that the ethical debate over whether xenotransplanta-
tion is justified is currently dominated by scepticism.
NEED FOR DISCUSSION AND ACTION
The issue of xenotransplantation can be seen as needing extensive debate and 
action not least by virtue of the contradictions and problems that it raises (sec-
tion VI):
> The academic community is called upon urgently to review and evaluate the 
state of R&D in a way which integrates overall the technological and professi-
onal aspects.
> Politics is called upon to follow the example of other states and the recom-
mendation of virtually all relevant expert opinions to draft and implement an 
appropriate regulatory strategy for xenotransplantation.
> Society as a whole is called upon to consider ethically the possible benefits of 
and damage arising from xenotransplantation and to develop socially tolerable 
(or at least acceptable) solutions for the problems facing us.
Corresponding activities would be particularly desirable as a way of linking 
the debate in Germany with the significantly more advanced state of discussion 
elsewhere. 
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